Elizabeth Trehu, Chief Medical Officer at Jounce Therapeutics, Inc. (JNCE), sold 7,724 shares at $21.24 ($165K) on 2018-03-05, disclosed to the SEC on 2018-03-07.
Open-market sale of $165k JNCE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.24 | 3,179 | $68K | 40.9% |
| 2 | $21.24 | 3,179 | $68K | 40.9% |
| 3 | $22.11 | 1,366 | $30K | 18.3% |
| Total | $21.39 avg | 7,724 | $165K | 100% |
| Filing → |
| JNCE | SELL | 2021-03-31 | $136K | — | Filing → |
| JNCE | SELL | 2021-01-22 | $78K | — | Filing → |
| JNCE | SELL | 2021-01-11 | $36K | — | Filing → |